Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Wegener's granulomatosis]

M Yoshida1

  • 1Renal Unit of Internal Medicine, Hachioji Medical Center of Tokyo Medical College.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1994
PubMed
Summary
This summary is machine-generated.

Wegener's granulomatosis (WG) is a multiorgan disease affecting airways and kidneys. Early diagnosis and stage-adapted immunosuppressive therapy significantly improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A DNA fragment homologous to F1-ATPase beta subunit was amplified from genomic DNA of Methanosarcina barkeri. Indication of an archaebacterial F-type ATPase.

FEBS letters·1992
Same author

Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol.

Cancer research·1992
Same author

Bartter's syndrome and growth hormone replacement.

Lancet (London, England)·1992
Same author

Substrate specificity of the Trypanosoma cruzi trans-sialidase.

Glycobiology·1992
Same author

Two types of septic shock classified by the plasma levels of cytokines and endotoxin.

Circulatory shock·1992
Same author

Elevated expression of the ornithine decarboxylase gene in human esophageal cancer.

Cancer research·1992
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Rheumatology
  • Pathology

Context:

  • Wegener's granulomatosis (WG) is a systemic vasculitis.
  • It characteristically affects the upper and lower respiratory tracts and kidneys (ELK classification).
  • Histological findings progress through four distinct stages.

Purpose:

  • To describe the key features of Wegener's granulomatosis.
  • To highlight the diagnostic significance of anti-neutrophil cytoplasmic antibodies (ANCA).
  • To outline the therapeutic approach and its impact.

Summary:

  • WG involves inflammation, necrosis, and granuloma formation in small to medium-sized vessels.
  • Anti-proteinase-3 (c) ANCA is a crucial marker for assessing WG disease activity.
  • Treatment involves immunosuppressants like glucocorticoids and cyclophosphamide.

Related Experiment Videos

Impact:

  • Recognition of ANCA-WG association aids disease activity assessment.
  • Stage-adapted immunosuppressive therapy has dramatically improved the prognosis of WG.
  • Understanding WG pathology and treatment is vital for effective patient management.